• By

Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence.

October 4, 2010

Dr. S. Vincent Rajkumar, from the Division of Hematology at Mayo Clinic, discusses advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance and implications for recategorizing disease entities, which will be published in the October 2010 issue of Mayo Clinic Proceedings.

Please login or become a member to post a comment.